2Maria G D,Maria AL,Jose J G et al.Essential hypertension and histocompatibility antigens[J].Hypertension,1992;19:400-402.
3Fu M L,Herlitz H,Wallukat G et al.Non-desensitized positive chronotropic effect of anti-angiotension II receptor autoantibodies in a patient with malignant hypertension[J].Circulation,1996;94:40-46.
4Wallukat G,Homuth V,Fischer T et al.Patients with preeclampsia develop agonistic antibodies against the angiotension AT1 receptor[J].J Clin Invest,1999;1103:945-952.
5Liao Y H,Wei Y M,Wang M et al.Autoantibodies against AT1-re-ceptor and alphal-adrenergic receptor in patients with hypertension[J].Hypertens Res,2002;25:641-646.
6Pratt R E.Regulation of vascular smooth-muscle cell growth by angiotensin II[J].Blood Press,1996;2:6-9.
7Marrero M B,Bernhard Schieffer,Bing Li.Role of Janus kinase/singal transducer and activator of transcription and MAPK cascades in angiotensin Ⅱ and platelet-derived growth factor-induced VSMC proliferation[J].J Biological Chemistry,1997;272(39):24684-24690.
8Wang B,Liao Y H,Zhou Z H et al.Arterial structure changes in rats immunized by AT1-receptor peptide[J].Heart Vessels,2005;20:153-158.
9Theingi M T,Sergiy G S,Mary-Clare Day et al.Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation[J].Circulation,2004;110:1612-1619.
10Thomas Walther,Gerd Wallukat,Alexander Jank et al.Angiotensin Ⅱ type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature[J].Hypertension,2005; 46:1275-1279.
